Regulation
Abbott’s dual ablation catheter lands FDA approval
Abbott received FDA clearance for its TactiFlex Duo dual ablation catheter, following the device's CE mark approval in January 2026. The catheter enables physicians to perform both radiofrequency and cryoablation procedures using a single device, intended for cardiac arrhythmia treatment.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network